药物输送
靶向给药
纳米颗粒
药品
转铁蛋白
纳米技术
药理学
治疗指标
毒品携带者
化学
癌症研究
材料科学
医学
生物化学
作者
Ruhani Singh,Marck Nörret,Michael J. House,Yuriy Galabura,Michael Bradshaw,Diwei Ho,Robert C. Woodward,Timothy G. St. Pierre,Igor Luzinov,Nicole M. Smith,Lee Yong Lim,K. Swaminathan Iyer
出处
期刊:Small
[Wiley]
日期:2015-11-30
卷期号:12 (3): 351-359
被引量:67
标识
DOI:10.1002/smll.201502730
摘要
The paradigm of using nanoparticle‐based formulations for drug delivery relies on their enhanced passive accumulation in the tumor interstitium. Nanoparticles with active targeting capabilities attempt to further enhance specific delivery of drugs to the tumors via interaction with overexpressed cellular receptors. Consequently, it is widely accepted that drug delivery using actively targeted nanoparticles maximizes the therapeutic benefit and minimizes the off‐target effects. However, the process of nanoparticle mediated active targeting initially relies on their passive accumulation in tumors. In this article, it is demonstrated that these two tumor‐targeted drug delivery mechanisms are interrelated and dosage dependent. It is reported that at lower doses, actively targeted nanoparticles have distinctly higher efficacy in tumor inhibition than their passively targeted counterparts. However, the enhanced permeability and retention effect of the tumor tissue becomes the dominant factor influencing the efficacy of both passively and actively targeted nanoparticles when they are administered at higher doses. Importantly, it is demonstrated that dosage is a pivotal parameter that needs to be taken into account in the assessment of nanoparticle mediated targeted drug delivery.
科研通智能强力驱动
Strongly Powered by AbleSci AI